| 產(chǎn)品編號(hào) | bs-1845R-Gold |
| 英文名稱(chēng)1 | Rabbit Anti-LRIG2/Gold Conjugated antibody |
| 中文名稱(chēng) | 膠體金標(biāo)記的LRIG2抗體 |
| 別 名 | DKFZp451C181; KIAA0806; LIG2; leucine-rich repeats and immunoglobulin-like domains protein 2 precursor; LRIG2_HUMAN; UFS2; LIG-2. |
| 規(guī)格價(jià)格 | 100ul/2980元 購(gòu)買(mǎi) 大包裝/詢(xún)價(jià) |
| 說(shuō) 明 書(shū) | 100ul（10nm 15nm 35nm） |
| 研究領(lǐng)域 | 腫瘤 細(xì)胞生物 免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 激酶和磷酸酶 |
| 抗體來(lái)源 | Rabbit |
| 克隆類(lèi)型 | Polyclonal |
| 交叉反應(yīng) | (predicted: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Guinea Pig, ) |
| 產(chǎn)品應(yīng)用 | IEM=1:20-200 ICA=1:20-200 ChIP=1:20-200
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 117kDa |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | 0.4mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human LRIG2 |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 儲(chǔ) 存 液 | 0.02M TBS(pH8.2) with 1% BSA, 0.03% Proclin300. |
| 保存條件 | Store at 2-8 oC for 3-6 months. Avoid repeated freeze/thaw cycles. |
| 產(chǎn)品介紹 |
background: LRIG2 is produced in all human glioma cell lines and localizes to perinuclear compartments, cytoplasmic compartments and the cell surface. It acts as a negative feedback regulator of signaling through enhanced receptor ubiquitination and accelerated intracellular degradation. LRIG2 may function as a tumour suppressor since it downregulates the expression of EGF and the related proteins ErbB-2, ErbB-3 and ErbB-4, which all inhibit cancer cells from growth, migration and invasion. Subcellular Location: Cell membrane; Single-pass type I membrane protein. Cytoplasm. Tissue Specificity: Detected in all tissues analyzed. Similarity: Contains 3 Ig-like C2-type (immunoglobulin-like) domains. Contains 15 LRR (leucine-rich) repeats. Contains 1 LRRCT domain. Contains 1 LRRNT domain. Database links: Entrez Gene: 9860 Human Omim: 608869 Human SwissProt: O94898 Human Unigene: 448972 Human Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. LRIG1屬于LRIGs基因家族。LRIGs是新發(fā)現(xiàn)的一類(lèi)基因，在哺乳動(dòng)物體內(nèi)廣泛存在，目前發(fā)現(xiàn)該家族至少包括三個(gè)成員：LRIG1、LRIG2和LRIG3，是一類(lèi)結(jié)構(gòu)相似的跨膜糖蛋白，該蛋白人、鼠的同源性較高。 目前在腫瘤方面的研究較多，有研究認(rèn)為：LRIG1是通過(guò)下調(diào)EGFR的表達(dá)來(lái)抑制其下游重要信號(hào)傳導(dǎo)通路的激活而發(fā)揮抑癌作用，LRIG1在抑制腫瘤轉(zhuǎn)移中具有重要作用。 |
